Addus HomeCare (ADUS) Stock Forecast, Price & News

4 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Addus HomeCare in the last twelve months. There are currently 4 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "buy" ADUS shares.
View ADUS analyst ratings or view top-rated stocks.

4 equities research analysts have issued 12 month price objectives for Addus HomeCare's stock. Their ADUS share price forecasts range from $101.00 to $123.00. On average, they anticipate the company's stock price to reach $112.75 in the next year. This suggests a possible upside of 25.1% from the stock's current price.
View analysts price targets for ADUS or view top-rated stocks among Wall Street analysts.

Addus HomeCare's stock was trading at $99.49 at the start of the year. Since then, ADUS stock has decreased by 9.4% and is now trading at $90.15.
View the best growth stocks for 2023 here.

Addus HomeCare saw a drop in short interest in May. As of May 15th, there was short interest totaling 284,900 shares, a drop of 46.6% from the April 30th total of 533,100 shares. Based on an average daily trading volume, of 154,700 shares, the days-to-cover ratio is currently 1.8 days. Currently, 1.8% of the shares of the stock are sold short.
View Addus HomeCare's Short Interest.

The company is scheduled to release its next quarterly earnings announcement on Monday, August 7th 2023.
View our ADUS earnings forecast.

Addus HomeCare Co. (NASDAQ:ADUS) released its quarterly earnings data on Sunday, October, 31st. The company reported $0.91 EPS for the quarter, topping the consensus estimate of $0.89 by $0.02. The business had revenue of $216.66 million for the quarter, compared to the consensus estimate of $227.11 million. Addus HomeCare had a net margin of 5.15% and a trailing twelve-month return on equity of 8.87%. The business's revenue for the quarter was up 11.7% compared to the same quarter last year. During the same period last year, the firm posted $0.69 EPS.

ETFs with the largest weight of Addus HomeCare (NASDAQ:ADUS) stock in their portfolio include Invesco S&P SmallCap Health Care ETF (PSCH), SPDR S&P Health Care Services ETF (XHS), Argent Mid Cap ETF (AMID), Inspire Fidelis Multi Factor ETF (FDLS), Invesco S&P SmallCap Momentum ETF (XSMO), Invesco S&P SmallCap 600 Pure Growth ETF (RZG), SPDR S&P 600 Small Cap Growth ETF (SLYG) and iShares S&P Small-Cap 600 Growth ETF (IJT).

91 employees have rated Addus HomeCare Chief Executive Officer Dirk Allison on Glassdoor.com. Dirk Allison has an approval rating of 51% among the company's employees. This puts Dirk Allison in the bottom 25% of approval ratings compared to other CEOs of publicly-traded companies.

Based on aggregate information from My MarketBeat watchlists, some companies that other Addus HomeCare investors own include AbbVie (ABBV), Bank of America (BAC), Bristol-Myers Squibb (BMY), Gilead Sciences (GILD), Verizon Communications (VZ), CVS Health (CVS), Pfizer (PFE), Ulta Beauty (ULTA), Cisco Systems (CSCO) and Walt Disney (DIS).

Addus HomeCare trades on the NASDAQ under the ticker symbol "ADUS."

Addus HomeCare's stock is owned by many different institutional and retail investors. Top institutional investors include BlackRock Inc. (15.57%), Silvercrest Asset Management Group LLC (4.53%), Wellington Management Group LLP (4.18%), Dimensional Fund Advisors LP (3.84%), Principal Financial Group Inc. (3.84%) and State Street Corp (3.41%). Insiders that own company stock include Brian Poff, Darby Anderson, David W Tucker, Esteban Lopez, Laurie Manning, Mark L First, Michael D Wattenbarger, R Dirk Allison, Roberton James Stevenson, Sean Gaffney and W Bradley Bickham.
View institutional ownership trends.

Shares of ADUS stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

One share of ADUS stock can currently be purchased for approximately $90.15.

Addus HomeCare (NASDAQ:ADUS) has a market capitalization of $1.46 billion and generates $951.12 million in revenue each year. The company earns $46.03 million in net income (profit) each year or $3.10 on an earnings per share basis.

The company employs 33,182 workers across the globe.

Addus HomeCare's mailing address is 6801 GAYLORD PARKWAY, FRISCO TX, 75034. The official website for the company is www.addus.com. The company can be reached via phone at (469) 535-8200, via email at investorrelations@addus.com, or via fax at 630-487-2707.